Special Article | Open Access
Jenny Heathcote, "Clinical Trials in Chronic Liver Disease - What Do They Achieve?", Canadian Journal of Gastroenterology and Hepatology, vol. 18, Article ID 748749, 4 pages, 2004. https://doi.org/10.1155/2004/748749
Clinical Trials in Chronic Liver Disease - What Do They Achieve?
The past 30 years have seen rapid growth in the number of clinical trials in liver disease; due mostly to effective drug discovery programs by the pharmaceutical industry. The advantages associated with therapeutic trials in chronic liver disease, or any other disease for that matter, go far beyond potential benefit to the individual patient, other beneficiaries include the treating physician, the sponsoring agency and their investors, the institution/university and the general public. But there is always a downside to any experiment. The disadvantages and advantages of clinical trials in liver disease are the topics for this discussion.
Copyright © 2004 Canadian Association of Gastroenterology. This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution, and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes.